Abstract: A surgical implant made of a polymer, copolymer, polymer mixture or polymer composite that dissolves in the organ system. The manufacturing material is dyed with the coloring agent D&C Violet No. 2 or D&C Green No. 6. Preferably, the amount of the coloring agent is at most approximately 0.03 percent by weight and the implant is sterilized by radiation.

Abstract: A novel polymer composition is provided which includes a base material including a biodegradable polymer or copolymer, and a copolymer additive including one or more monomers imparting a tensile strength to the polymer composition at room temperature that is lower than a tensile strength at room temperature for the base material.

Abstract: A biodegradable implant and a method for manufacturing one. The implant comprises a matrix component containing at least one biodegradable polymer or copolymer and a plasticizer that is adapted to substantially reduce the rigidity of the implant. The plasticizer substantially exists from the implant after coming into contact with tissue fluids of the organ system in such a manner that the bending resistance of the implant prior to the insertion of the implant into the organ system is substantially lower than after its insertion into the organ system.

Abstract: Novel polymer compositions that are useful in the manufacture of medical implants, implants having osteogenic properties and methods of making said implants are disclosed. Polymer compositions comprise a base material including a polymer matrix of resorbable polymer(s) or copolymer(s), and N-methyl-2-pyrrolidone (NMP), wherein NMP is present in an amount imparting osteogenic properties for the composition.

Abstract: The present invention relates to novel mutants of bone morphogenetic proteins (BMPs) useful as inhibitors of heterotopic ossification. Specifically, the present invention relates to novel mutants containing only the entire region involved in the formation of finger 2 including the wrist epitope of a BMP with a specific cysteine residue or specific cysteine residues replaced by a different amino acid. The present invention also relates pharmaceutical compositions containing these mutants and to the use of the mutants and pharmaceutical compositions in therapy.

Abstract: A tool for making threaded surgical holes. The tool has a drilling tip that drills the hole and a thread-forming section that forms the thread in the hole and comprises a thread that shapes bone. The height of the thread of the thread-forming section is substantially at least 10% of the outer diameter of the thread-forming section.

Abstract: A storage for surgical fixation devices and an arrangement for the storage for surgical fixation devices. The storage for fixation devices comprises fixation device slots for at least one fixation device and a guide that is arranged to guide a counter element of an installation tool to a contact section of a fixation device located in the fixation device slot. The arrangement comprises a space for the fixation device storage, to which the storage for fixation devices can be arranged, and a guide for an installation tool, the guide being arranged to guide a counter element of the installation tool to a contact section of a fixation device located in the fixation device slot.

Abstract: A bone plate for supporting bone. At least one shaping area reducing the shaping resistance of the shape of the bone plate and the bending and/or torsional resistance of the body is arranged in the section of the bone plate between fixation holes.